Article · Wikipedia archive · Last revised Jul 11, 2026

1BP-LSD

1BP-LSD, also known as 1-(3- propionyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to be a prodrug of LSD. The drug was encountered online as a novel designer drug in December 2025. 1BP-LSD has been sold in the form of blotter containing 175 and 200 μg per tab. It has been said to be considered to be the official legal successor of 1S-LSD, which was banned in Germany soon before 1BP-LSD's appearance. The effects of 1BP-LSD are said to be similar to those of 1S-LSD and to include visual changes, altered perception of time and space, heightened emotions, and increased creativity. 1BP-LSD is not an explicitly controlled substance in the United States or in Canada.

Last revised
Jul 11, 2026
Read time
≈ 1 min
Length
231 w
Citations
9
Source
Wikipedia ↗
1BP-LSD
Clinical data
Other names1-(3-(Tetramethyldioxa-borolane)propionyl)-LSD
Routes of
administration		Oral1
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-4-(4-(4,4,5,5-tetraethyl-1,3,2-dioxaborolan-2-yl)benzoyl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Chemical and physical data
FormulaC37H48BN3O4
Molar mass609.62 g·mol−1
3D model (JSmol)
  • CCN(C([C@H](C=C1[C@@]2([H])CC3=CN(C(CCB4OC(C)(C)C(C)(C)O4)=O)C5=CC=CC1=C35)CN2C)=O)CC
  • InChI=1S/C29H40BN3O4/c1-8-32(9-2)27(35)20-15-22-21-11-10-12-23-26(21)19(16-24(22)31(7)17-20)18-33(23)25(34)13-14-30-36-28(3,4)29(5,6)37-30/h10-12,15,18,20,24H,8-9,13-14,16-17H2,1-7H3/t20-,24-/m1/s1
  • Key:WTJNMHVFTSXKOI-HYBUGGRVSA-N

1BP-LSD, also known as 1-(3-(tetramethyldioxaborolane)propionyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).1 It is thought to be a prodrug of LSD.1 The drug was encountered online as a novel designer drug in December 2025.1 1BP-LSD has been sold in the form of blotter containing 175 and 200 μg per tab.1 It has been said to be considered to be the official legal successor of 1S-LSD, which was banned in Germany soon before 1BP-LSD's appearance.1 The effects of 1BP-LSD are said to be similar to those of 1S-LSD and to include visual changes, altered perception of time and space, heightened emotions, and increased creativity.1 1BP-LSD is not an explicitly controlled substance in the United States2 or in Canada.3

See also

See also

References

References

  1. "1BP-LSD". АИПСИН (in Russian). Retrieved 5 January 2026.
  2. Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
  3. "Controlled Drugs and Substances Act". Department of Justice Canada. 5 December 2025. Retrieved 20 January 2026.
External links